How LifeMD pricing works as a subscription: the recurring membership fee, what each tier bundles, the medication cost that sits outside it, and the renewal terms worth reading first. Independent editorial review, current as of April 2026, plus the genetic baseline no tier includes.

Felix Health charges $149-$289/mo for GLP-1 treatment. PlexusDx offers compounded semaglutide and tirzepatide at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed pharmacies. Genetic predispositions and biomarker context may inform cost-effectiveness and treatment alignment with individual health profiles.

Agelessrx offers compounded semaglutide and tirzepatide at various price points. Understanding pricing models, what's included in each tier, and how genetic predispositions affect medication suitability can help patients make informed decisions about GLP-1 therapy cost and clinical fit.

Orderly Meds pricing varies by medication and subscription tier.

Henry Meds prices its GLP-1 program per medication and advertises its lowest twelve-month prepaid rate, so the monthly figure you actually pay is higher. This independent review breaks down the pricing ladder, what each plan bundles, the cancellation terms, and the genetic context PlexusDx layers on before any protocol begins.

This independent editorial breaks down how Ivim Health prices its GLP-1 telehealth program — the membership fee, medication cost, dispensing pathway, and billing cadence that drive the monthly total — and contrasts it with published PlexusDx protocol pricing and upstream genetic context.

Curai Health offers telehealth-based GLP-1 prescription services with program and medication fees. Understanding their pricing structure helps patients evaluate total cost of care and compare with compounded pharmacy options tailored to individual clinical profiles.

9Amhealth pricing varies by program tier and medication type. Understanding total costs—including consultations, labs, and ongoing prescriptions—helps patients evaluate GLP-1 options.

Brello pricing includes medication costs, provider consultation fees, and program membership. Understanding the complete cost structure helps patients evaluate GLP-1 treatment affordability against other options, including compounded alternatives with transparent pricing models.

This independent Fella Health review examines the business model behind men-focused GLP-1 telehealth: subscription logic, the prescribing-to-fulfillment chain, and the real trade-offs of the design. It closes with the metabolic pathway context that no service-level review can capture on its own.

Strut Health offers compounded GLP-1 medications through licensed pharmacies. This review evaluates compounding standards, licensure requirements, and how genetic insights can inform more personalized treatment selection beyond generic protocols.

A breakdown of how Direct Meds prices its GLP-1 program, including the subscription structure and what drives the monthly total. It explains the cash-pay and branded-versus-compounded split, references the April 2026 telehealth market range, and describes the one cost input no quote includes: your baseline genetics.

An independent editorial review of Agile Health that starts from the criteria that actually matter for trust: state-licensed clinicians, the 503A compounding pathway, real clinical oversight, and pricing transparency. It also covers the pathway-level genetic context that no telehealth review score can capture before you commit.

Felix Health operates a telehealth model for GLP-1 prescriptions with flat monthly pricing. This review evaluates their business structure, clinical oversight, and how their approach compares to compounded GLP-1 options available through licensed 503A pharmacies.

TRT Nation Review is a testosterone replacement therapy platform that has expanded into GLP-1 compounded peptide offerings.

Orderly Meds Reviews is a comparison platform for compounded GLP-1 providers. This guide explains how to assess pharmacy quality, verify licensing, and understand the clinical differences between reputable compounding services and cost-cutting alternatives.

Noom and Weightwatchers offer distinct behavioral frameworks for weight management—psychology-first vs. point-based systems—but neither replaces medical evaluation or medication therapy.

Mochi is a telehealth platform offering GLP-1 medications through remote consultations. This review evaluates Mochi's clinical approach, cost structure, and how precision-based alternatives like compounded GLP-1 with genetic assessment may support more individualized treatment planning.

LifeMD is a telehealth platform offering remote GLP-1 prescription services for weight loss and diabetes management. This review examines LifeMD's model, costs, clinical oversight, and how it compares to compounded GLP-1 providers like PlexusDx.

Hers is a telehealth platform offering prescription GLP-1 medications for weight management through remote consultations. This review examines Hers' clinical model, costs, eligibility criteria, and how precision-based approaches like genetic assessment may complement telehealth evaluation.

GoodLife Meds Review is a telehealth GLP-1 provider offering compounded semaglutide and tirzepatide.

Fridays is a telehealth GLP-1 program dispensing compounded semaglutide and tirzepatide through licensed 503A pharmacies. This independent PlexusDx review compares its advertised month-to-month pricing, pharmacy standards, and support with the PlexusDx approach.

Direct Meds Review is a platform helping patients evaluate online GLP-1 providers by assessing credentials, safety standards, and personalization frameworks. Understanding these criteria supports informed decisions about compounded peptide options and provider selection.

Brello is a telehealth platform offering GLP-1 medications through a subscription model with tiered clinical assessments.

Mochi and Remedy Meds are telehealth platforms offering GLP-1 access through virtual consultations. Both connect patients to medications, but differ in sourcing, pricing, and clinical oversight models.

Noom and Hims are two distinct telehealth platforms offering GLP-1 medication programs, each with different business models, clinical oversight structures, and personalization strategies.

Remedy Meds Discount positions itself as an affordable GLP-1 pathway, but cost alone doesn't determine clinical suitability or safety.

Noom emphasizes behavioral psychology and habit change through app-based coaching, while Remedy Meds centers on pharmacological interventions for weight loss. Each platform serves different preferences: psychology-first versus medication-supported approaches.

Remedy Meds and Henry Meds are telehealth platforms offering GLP-1 medications, but they differ in clinical oversight, pricing models, and personalization approaches. Understanding these distinctions helps patients select a provider aligned with their medical needs and preferences.

Noom emphasizes behavioral psychology and habit change through mobile coaching, while Mochi provides GLP-1 medication management via virtual care. Each serves different needs depending on clinical preference, genetics, and lifestyle readiness.